Publications by authors named "Alejandro Falcon"

Claim this Profile
M
Multidisciplinary management of persistent severe cancer pain: a collaborative European approach.
Denis Dupoiron, María Luz Padilla, Monica Iorfida, Alejandro Falcon, Matthew R D Brown

Support Care Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Agent Divarasib in Patients With -Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.
Adrian G Sacher, Wilson H Miller, Manish R Patel, Luis Paz-Ares, Armando Santoro, Alejandro Falcon

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.
Johann S de Bono, Anja Williams, Ignacio Melero, Anuradha Jayaram, Jessica E Hawley, Alejandro Falcon

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I results on the efficacy, safety and pharmacokinetics of lurbinectedin and irinotecan in advanced solid tumors.
Alejandro Falcón, Santiago Ponce, Gregory M Cote, Ana Gil, Jessica J Lin

Invest New Drugs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression.
Isabel Miras, Ana Gil, Marta Benavent, María Ángeles Castilla, Begoña Vieites

Ther Adv Med Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Jayesh Desai, Guzman Alonso, Se Hyun Kim, Andres Cervantes, Thomas Karasic, Alejandro Falcon

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a G12C Mutation.
Adrian Sacher, Patricia LoRusso, Manish R Patel, Wilson H Miller, Elena Garralda, Alejandro Falcon

N Engl J Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer.
Mónica Cejuela, Ana Gil-Torralvo, M Ángeles Castilla, M Ángeles Domínguez-Cejudo, Alejandro Falcón

Int J Mol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.
Nataliya Mar, Yousef Zakharia, Alejandro Falcon, Rafael Morales-Barrera, Begona Mellado

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data.
Tamara Díaz-Redondo, Rocio Lavado-Valenzuela, Begoña Jimenez, Tomas Pascual, Fernando Gálvez

Front Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
Alberto Ocana, Marta Gil-Martin, Silvia Antolín, María Atienza, Álvaro Montaño

Breast Cancer Res Treat· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature.
Isabel Tena, Garima Gupta, Marcos Tajahuerce, Marta Benavent, Manuel Cifrián, Alejandro Falcon

Clin Med Insights Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inositol phosphoceramide synthase is a regulator of intracellular levels of diacylglycerol and ceramide during the G1 to S transition in Saccharomyces cerevisiae.
Jorge Cerbón, Alejandro Falcon, Carlos Hernández-Luna, David Segura-Cobos

Biochem J· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis